phase readout
saveNCT01523171: Phase II, Open Label, Single Arm Study of SAR302503 In Myelofibrosis Patients Previously Treated With Ruxolitinib
TERMINATEDupdated 1d ago
community read0 votes
Sponsor: Bristol-Myers Squibb. Phase: PHASE2. Conditions: Hematopoietic Neoplasm
view source ↗
comments(0)
5-min edit window · permanent after that